Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 148

1.

Prognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetes.

Doycheva I, Patel N, Peterson M, Loomba R.

J Diabetes Complications. 2013 May-Jun;27(3):293-300. doi: 10.1016/j.jdiacomp.2012.10.008. Epub 2013 Jan 9. Review.

PMID:
23312215
[PubMed - indexed for MEDLINE]
2.

The epidemiology of nonalcoholic fatty liver disease in adults.

Clark JM.

J Clin Gastroenterol. 2006 Mar;40 Suppl 1:S5-10. Review.

PMID:
16540768
[PubMed - indexed for MEDLINE]
3.

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Starley BQ, Calcagno CJ, Harrison SA.

Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Review.

PMID:
20432259
[PubMed - indexed for MEDLINE]
4.

Nonalcoholic steatohepatitis.

Brunt EM.

Semin Liver Dis. 2004 Feb;24(1):3-20. Review.

PMID:
15085483
[PubMed - indexed for MEDLINE]
5.

Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis.

Anstee QM, Targher G, Day CP.

Nat Rev Gastroenterol Hepatol. 2013 Jun;10(6):330-44. doi: 10.1038/nrgastro.2013.41. Epub 2013 Mar 19. Review.

PMID:
23507799
[PubMed - indexed for MEDLINE]
6.

Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH.

Salomao M, Yu WM, Brown RS Jr, Emond JC, Lefkowitch JH.

Am J Surg Pathol. 2010 Nov;34(11):1630-6. doi: 10.1097/PAS.0b013e3181f31caa.

PMID:
20975341
[PubMed - indexed for MEDLINE]
7.

Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Farrell GC, Larter CZ.

Hepatology. 2006 Feb;43(2 Suppl 1):S99-S112. Review.

PMID:
16447287
[PubMed - indexed for MEDLINE]
8.

Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients.

Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, Goodman Z, Younossi ZM.

Obes Surg. 2005 Mar;15(3):310-5.

PMID:
15826462
[PubMed - indexed for MEDLINE]
9.

Prevalence, gender, ethnic variations, and prognosis of NASH.

Hashimoto E, Tokushige K.

J Gastroenterol. 2011 Jan;46 Suppl 1:63-9. doi: 10.1007/s00535-010-0311-8. Epub 2010 Sep 16. Review.

PMID:
20844903
[PubMed - indexed for MEDLINE]
10.

Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk.

Pacifico L, Nobili V, Anania C, Verdecchia P, Chiesa C.

World J Gastroenterol. 2011 Jul 14;17(26):3082-91. doi: 10.3748/wjg.v17.i26.3082. Review.

PMID:
21912450
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.

Bugianesi E, Vanni E, Marchesini G.

Curr Diab Rep. 2007 Jun;7(3):175-80. Review.

PMID:
17547834
[PubMed - indexed for MEDLINE]
12.

[Pathophysiology of non-alcoholic steatohepatitis. An insulin resistance overview].

Macías-Rodríguez RU, Torre A.

Rev Invest Clin. 2009 Mar-Apr;61(2):161-72. Review. Spanish.

PMID:
19637730
[PubMed - indexed for MEDLINE]
13.

Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.

Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, Bertelli C, Fatta E, Bignamini D, Marchesini G, Fargion S.

Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.

PMID:
18752331
[PubMed - indexed for MEDLINE]
14.

[Epidemiology and natural history of nonalcoholic fatty liver disease].

Pais R, Ratziu V.

Rev Prat. 2012 Dec;62(10):1416-8, 1420-1. Review. French.

PMID:
23424924
[PubMed - indexed for MEDLINE]
15.

Nonalcoholic fatty liver disease and the metabolic syndrome: clinical implications and treatment.

Rahimi RS, Landaverde C.

Nutr Clin Pract. 2013 Feb;28(1):40-51. doi: 10.1177/0884533612470464. Epub 2013 Jan 3. Review.

PMID:
23286927
[PubMed - indexed for MEDLINE]
16.
17.

Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis?

Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ.

Arch Pathol Lab Med. 2008 Nov;132(11):1761-6. doi: 10.1043/1543-2165-132.11.1761.

PMID:
18976012
[PubMed - indexed for MEDLINE]
18.

The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease.

McCullough AJ.

Clin Liver Dis. 2004 Aug;8(3):521-33, viii. Review.

PMID:
15331061
[PubMed - indexed for MEDLINE]
19.

Immunological and molecular basis of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease.

Radwan MM, Radwan BM, Nandipati KC, Hunter WJ 3rd, Agrawal DK.

Expert Rev Clin Immunol. 2013 Aug;9(8):727-38. doi: 10.1586/1744666X.2013.816484. Review.

PMID:
23971751
[PubMed - indexed for MEDLINE]
20.

Obesity and hepatocellular carcinoma.

Caldwell SH, Crespo DM, Kang HS, Al-Osaimi AM.

Gastroenterology. 2004 Nov;127(5 Suppl 1):S97-103. Review.

PMID:
15508109
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk